Somatic SF3B1 hotspot mutation in prolactinomas
NATURE COMMUNICATIONS(2020)
摘要
The genetic basis and corresponding clinical relevance of prolactinomas remain poorly understood. Here, we perform whole genome sequencing (WGS) on 21 patients with prolactinomas to detect somatic mutations and then validate the mutations with digital polymerase chain reaction (PCR) analysis of tissue samples from 227 prolactinomas. We identify the same hotspot somatic mutation in splicing factor 3 subunit B1 ( SF3B1 R625H ) in 19.8% of prolactinomas. These patients with mutant prolactinomas display higher prolactin (PRL) levels ( p = 0.02) and shorter progression-free survival (PFS) ( p = 0.02) compared to patients without the mutation. Moreover, we identify that the SF3B1 R625H mutation causes aberrant splicing of estrogen related receptor gamma (ESRRG), which results in stronger binding of pituitary-specific positive transcription factor 1 (Pit-1), leading to excessive PRL secretion. Thus our study validates an important mutation and elucidates a potential mechanism underlying the pathogenesis of prolactinomas that may lead to the development of targeted therapeutics.
更多查看译文
关键词
Endocrine system and metabolic diseases,Mutation,Science,Humanities and Social Sciences,multidisciplinary
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要